CD28 and cancer: Moreover, the circulating number of CD8 + CD28-CD127-CD39 + Treg, a CD8 + Treg subset that heavily infiltrates human cancer [44, 45], showed a highly significant predicting value since reduced (with respect to baseline) levels of these cells at 180 days after GX301 vaccination predisposed patients to a prolonged survival.